Over €2 billion grant funding in Q1 2025 for investments in start-ups
The authorities are preparing to launch more than 15 separate funding lines, with allocations ranging from €50,000 to more than €57M.
The authorities are preparing to launch more than 15 separate funding lines, with allocations ranging from €50,000 to more than €57M.
The total value of the investment amounted to RON 7.788.593,26, of which 70% represents European funds, which was successfully attracted by the REI Grup team.
InvestALIM results: out of a total of 37 companies - eight are projects successfully managed by the REI team.
The Modernisation Fund, Regional Programmes, Rural Development - Agriculture and Start-up Nation 2024 receive the largest allocations. Financial support ranges from €20,000 to over €57 million.
The Ministry of Finance is preparing a new state aid scheme for investments, similar to GD 807/2014: annual budget is estimated at €150 million.

Electrica has completed the Artificial Intelligence for Active Energy Management (AIAE) project, developed in partnership with Romanian startup Renergia and the Technical University of Cluj-Napoca.
Uber Technologies announced new products and features at its annual Go-Get product event, including hotel bookings and travel tools that are planned to roll out globally in the coming months.
Greenvolt Next Romania has signed an agreement with Sam Mills to develop a 2MW photovoltaic project with a 10.03 MWh battery storage system in Satu Mare.
Fitch Ratings has upgraded CEC Bank's Long-Term Issuer Default Rating from BB to BB+ with a Stable Outlook, following the publication of Fitch's updated Bank Rating Criteria on 8 May 2026.
The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.